市场调查报告书
商品编码
1466184
脑脊髓液 (CSF) 管理市场:全球规模、份额、趋势分析、机会、预测报告,2019-2030Cerebrospinal Fluid Management Market - Global Size, Share, Trend Analysis, Opportunity and Forecast Report, 2019-2030, Segmented By Product; By End User; By Region |
到 2030 年,全球脑脊髓液 (CSF) 管理市场规模将增加一倍以上,达到 30 亿美元
由于水脑症和其他神经系统疾病的负担日益增加,以及老年人口的不断增长,全球脑脊髓液(CSF)管理市场正在蓬勃发展。
领先的策略咨询和市场研究公司 BlueWeave Consulting 在最近的一项研究中估计,2023 年全球脑脊髓液 (CSF) 管理市场规模为 13.7 亿美元。 BlueWeave 预测,在 2024-2030 年预测期内,全球脑脊髓液 (CSF) 管理市场规模将以 5.12% 的复合年增长率成长,到 2030 年达到 29.8 亿美元。脑脊髓液相关疾病(如脑膜炎、蜘蛛膜下腔出血和水脑症)发生率的上升是推动全球脑脊髓液(CSF)管理市场的关键因素之一。此外,在分析期间,全球脑脊髓液(CSF)管理市场预计将受到老年人口增加以及帕金森氏症和阿兹海默症疾病发病率增加的推动。
机会:新兴国家加大对医疗保健的投资
包括印度、巴西在内的主要新兴国家由于活性化,正在活性化投资医疗领域,以加强本国的医疗基础设施。开发中国家和低收入国家水脑症的高盛行率主要是由于社会经济地位低和缺乏叶酸补充所造成的。因此,对脑脊髓液(CSF)管理的需求预计将增加并推动整个市场。
地缘政治紧张局势加剧对全球脑脊髓液(CSF)管理市场的影响
地缘政治紧张局势的加剧对全球脑脊髓液(CSF)管理市场的成长产生负面影响。战争、衝突和种族灭绝等情况影响患者获得适当的医疗保健服务,并导致医疗用品短缺。例如,俄罗斯和以色列分别摧毁了乌克兰和巴勒斯坦的几家医院,导致整个医疗系统崩坏,许多医护人员流散。许多面临地缘政治紧张局势的其他国家获得脑脊髓液(CSF)管理医疗用品的资源有限,这限制了全球市场的成长。
全球脑脊髓液 (CSF) 管理市场
按细分市场分類的覆盖范围
全球脑脊髓液 (CSF) 管理市场 – 依最终用户分类
根据最终用户,全球脑脊髓液(CSF)管理市场分为儿童、成人和老年。由于儿童先天性水脑症的盛行率不断上升,儿童市场占有最高的市场占有率。先天性水脑症是指从出生起脑中就有过多的脑脊髓液 (CSF)。因此,儿童分流手术的数量也在快速成长,推动了全球脑脊髓液(CSF)管理市场的发展。
全球脑脊髓液 (CSF) 管理市场 - 按地区
该研究报告对全球脑脊髓液(CSF)管理市场进行了深入研究,包括五个主要地区的众多各国市场:北美、欧洲、亚太地区(APAC)、拉丁美洲、中东非洲。北美主导全球脑脊髓液(CSF)管理市场。该地区在市场上的主导地位主要是由于老年人口的增长和神经病变的流行。此外,该领域的广泛研发活动以及美国FDA 对新产品的核准预计将为预测期内脑脊髓液 (CSF) 管理市场的主要参与者提供有利的成长机会。
竞争格局
全球脑脊髓液 (CSF) 管理市场的主要企业包括 Medtronic Plc、B. Braun Melsungen AG、Integra Lifesciences、Natus Medical Incorporated、Sophysa、Aesculap AG、Spiegelberg GmbH &Co.KG、Moeller Medica、IRRAS AB、Argi Group、索菲萨。
这些公司正在采取各种策略,例如併购、合作、合资、授权合约和新产品推出,以进一步增加其市场占有率。
该报告的详细分析提供了有关成长潜力、未来趋势和全球脑脊髓液(CSF)管理市场的资讯。它还涵盖了推动市场总规模预测的因素。该报告致力于提供全球脑脊髓液(CSF)管理市场的最新技术趋势以及产业见解,以帮助决策者做出适当的策略决策。此外,我们也分析了市场的成长动力、挑战和竞争力。
Global Cerebrospinal Fluid (CSF) Management Market Size Set to More Than Double Touching USD 3 Billion by 2030
Global Cerebrospinal Fluid (CSF) Management Market is flourishing because of the increasing burden of hydrocephalus and other neurological disorders and growing geriatric population.
BlueWeave Consulting, a leading strategic consulting and market research firm, in its recent study, estimated the Global Cerebrospinal Fluid (CSF) Management Market size at USD 1.37 billion in 2023. During the forecast period between 2024 and 2030, BlueWeave expects the Global Cerebrospinal Fluid (CSF) Management Market size to expand at a CAGR of 5.12% reaching a value of USD 2.98 billion by 2030. The rising incidence of illnesses linked to CSF, such as meningitis, subarachnoid hemorrhage, and hydrocephalus, is one of the main driving reasons for the Global Cerebrospinal Fluid (CSF) Management Market. Furthermore, it is projected that the Global Cerebrospinal Fluid (CSF) Management Market will be driven by a growing elderly population and the increasing incidence of illnesses like Parkinson's and Alzheimer's during the period in analysis.
Opportunity: Growing investments in healthcare sector by developing countries
Major emerging economies, including India and Brazil, have been significantly investing in their healthcare sector to strengthen the healthcare infrastructure across their countries owing to an increasing patient pool and to boost medical tourism in their respective countries. The high prevalence of hydrocephalus in developing and lower-income countries is mainly attributed to low socioeconomic status and a lack of folic acid supplementation. As a result, the demand for cerebrospinal fluid (CSF) management is projected to grow, driving the overall market.
Impact of Escalating Geopolitical Tensions on Global Cerebrospinal Fluid (CSF) Management Market
The escalating geopolitical tensions negatively impact the growth of the Global Cerebrospinal Fluid (CSF) Management Market. Situations like war, conflicts, and genocide impact the patient's accessibility to proper healthcare services and result in a shortage of medical supplies. Russia and Israel, for instance, destroyed several hospitals in Ukraine and Palestine, respectively, which resulted in the breakdown of the entire healthcare system and the displacement of many healthcare workers. Many other countries that are facing geopolitical tensions have limited resources to acquire medical supplies for performing cerebrospinal fluid (CSF) management, which limits its global market growth.
Global Cerebrospinal Fluid (CSF) Management Market
Segmental Coverage
Global Cerebrospinal Fluid (CSF) Management Market - By End User
Based on the end user, the Global Cerebrospinal Fluid (CSF) Management Market is segmented into pediatric, adult, and geriatric. The pediatric segment accounts for the highest market share owing to the increasing prevalence of congenital hydrocephalus among children. Overabundance of cerebrospinal fluid (CSF) in the brain from birth results in congenital hydrocephalus. As a result, the number of shunt procedures performed on children is also rising at a high rate, driving the global cerebrospinal fluid (CSF) management market.
Global Cerebrospinal Fluid (CSF) Management Market - By Region
The in-depth research report on the Global Cerebrospinal Fluid (CSF) Management Market covers a number of country-specific markets across five major regions: North America, Europe, Asia Pacific (APAC), Latin America, and Middle East and Africa. North America dominates the Global Cerebrospinal Fluid (CSF) Management Market. The region's dominance in the market is mainly attributed to the growing elderly population and the prevalence of nervous disorders. Furthermore, extensive research and development activities in this field and approvals of new products by the US FDA are anticipated to present lucrative growth opportunities to the major players in the Cerebrospinal Fluid (CSF) Management Market over the forecast period.
Competitive Landscape
Major players operating in the Global Cerebrospinal Fluid (CSF) Management Market include Medtronic Plc, B. Braun Melsungen AG, Integra Lifesciences, Natus Medical Incorporated, Sophysa, Aesculap AG, Spiegelberg GmbH & Co. KG, Moeller Medica, IRRAS AB, Argi Group, and Sophysa.
These companies employ various strategies to further enhance their market share, including mergers and acquisitions, partnerships, joint ventures, license agreements, and new product launches.
The in-depth analysis of the report provides information about growth potential, upcoming trends, and the Global Cerebrospinal Fluid (CSF) Management Market. It also highlights the factors driving forecasts of total market size. The report promises to provide recent technology trends in the Global Cerebrospinal Fluid (CSF) Management Market and industry insights to help decision-makers make sound strategic decisions. Furthermore, the report also analyzes the growth drivers, challenges, and competitive dynamics of the market.
*Financial information of non-listed companies can be provided as per availability.
**The segmentation and the companies are subject to modifications based on in-depth secondary research for the final deliverable